Stocks witnessing selling pressure in February 2021

Stocks witnessing selling pressure in February 2021

Henil Shah

In our last update, we had listed the top five stocks that attracted fund managers in the month of February 2021. Now, let us have a look at the top five stocks that witnessed a lot of selling from fund managers. 

 

Stock name 

Sector 

Classification 

Net qty sold 

Approx. sell value (Rs crore) 

Bharti Airtel Ltd 

Media & communications 

Large-cap 

5,03,82,625 

2,796.03 

HDFC Bank Ltd 

Financials 

Large-cap 

99,58,298 

1,456.36 

Reliance Industries Ltd 

Energy 

Large-cap 

72,47,397 

1,423.26 

Housing Development Finance Corporation Ltd 

Financials 

Large-cap 

54,31,409 

1,335.35 

Hindalco Industries Ltd 

Metals 

Large-cap 

3,10,10,677 

878.46 

 

 

This time in the month of February 2021, the top five stocks that fund managers sold are majorly from the financial sector. HDFC Bank Ltd and Housing Development Finance Corporation Ltd were at the top-selling list of fund managers where the average sell value was around Rs 1,456.36 crore and Rs 1,335.35 crore, respectively. 

If we look purely sector-wise then the financial sector seems to be on the top with an approximate sell value of Rs 6,707.26 crore, followed by media & communications as well as the healthcare sector with an approximate sell value of Rs 3,351.92 crore and Rs 3,329.10 crore, respectively. 

Now if we take a look market cap-wise then this time around, large-cap witnessed the highest selling with an approximate sell value of Rs 18,537.53 crore, followed by mid-cap and small-cap with an approximate sell value of Rs 6,409.98 crore and Rs 3,343.20 crore, respectively. 

The intention of the above analysis is only for the purpose of understanding the activity of mutual funds as well as gauging the fund managers’ approach and it’s by no means, a recommendation to buy or sell. It is always advisable to have a financial plan in place, which must be followed with discipline and investments in mutual funds being made to be based on your individual risk assessment. 

Previous Article Stocks attracting fund managers in February 2021
Next Article Strides Pharma subsidiary gets USFDA nod for Potassium Chloride Oral Solution
Rate this article:
5.0

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR